Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Sood

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
BMC Endocrine Disorders|June 1, 2012
Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial dataDenise E Bonds, Michael E Miller, Jim Dudl, et al.
Archives of Pediatrics & Adolescent Medicine|August 6, 2008
Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorderDaniel J Cox, Amori Yee Mikami, Brian S Cox, et al.
Diabetes Care|August 9, 2019
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)Deborah J Wexler, Heidi Krause-Steinrauf, Jill P Crandall, et al.
Journal of Alzheimer'S Disease : JAD|January 25, 2005
Novel analogs of choline as potential neuroprotective agentsJerry J Buccafusco, J Warren Beach, Alvin V Terry, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|January 11, 2021
The Design and Implementation of a Heart Disease Reversal Program in the Veterans Health Administration: Before and During the COVID-19 PandemicThemis A Yiaslas, Ajay Sood, Gregory Ono, et al.
Diabetologia|July 3, 2014
Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trialZubin Punthakee, Michael E Miller, Debra L Simmons, et al.
Neurology|September 20, 2019
Quality improvement in neurology: Mild cognitive impairment quality measurement setNorman L Foster, Mark W Bondi, Rohit Das, et al.
Diabetes Care|February 25, 2011
Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trialRoger T Anderson, K M Venkat Narayan, Patricia Feeney, et al.
Medrxiv : the Preprint Server for Health Sciences|September 10, 2024
Antihypertensive medications and dementia in older adults with hypertensionSuzanne G Orchard, Zhen Zhou, Michelle Fravel, et al.
Diabetes Care|March 6, 2014
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trialKaren L Margolis, Patrick J O'Connor, Timothy M Morgan, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
BMC Endocrine Disorders|June 1, 2012
Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial dataDenise E Bonds, Michael E Miller, Jim Dudl, et al.
Archives of Pediatrics & Adolescent Medicine|August 6, 2008
Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorderDaniel J Cox, Amori Yee Mikami, Brian S Cox, et al.
Diabetes Care|August 9, 2019
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)Deborah J Wexler, Heidi Krause-Steinrauf, Jill P Crandall, et al.
Journal of Alzheimer'S Disease : JAD|January 25, 2005
Novel analogs of choline as potential neuroprotective agentsJerry J Buccafusco, J Warren Beach, Alvin V Terry, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|January 11, 2021
The Design and Implementation of a Heart Disease Reversal Program in the Veterans Health Administration: Before and During the COVID-19 PandemicThemis A Yiaslas, Ajay Sood, Gregory Ono, et al.
Diabetologia|July 3, 2014
Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trialZubin Punthakee, Michael E Miller, Debra L Simmons, et al.
Neurology|September 20, 2019
Quality improvement in neurology: Mild cognitive impairment quality measurement setNorman L Foster, Mark W Bondi, Rohit Das, et al.
Diabetes Care|February 25, 2011
Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trialRoger T Anderson, K M Venkat Narayan, Patricia Feeney, et al.
Medrxiv : the Preprint Server for Health Sciences|September 10, 2024
Antihypertensive medications and dementia in older adults with hypertensionSuzanne G Orchard, Zhen Zhou, Michelle Fravel, et al.
Diabetes Care|March 6, 2014
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trialKaren L Margolis, Patrick J O'Connor, Timothy M Morgan, et al.
Pageof 5